查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363026

分子細胞遺傳學市場規模、佔有率、趨勢分析報告：按用途、按技術、按產品、按最終用途、按地區、細分市場趨勢，2023-2030 年

Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 236 Pages | 商品交期: 2-10個工作天內

價格

分子細胞遺傳學市場成長與趨勢：

Grand View Research 的最新報告顯示，到 2030 年，全球分子細胞遺傳學市場預計將達到 44.6 億美元。

預計2023年至2030年該市場將以10.6%的年複合成長率擴張。分子細胞遺傳學在臨床病理學檢測中的滲透率不斷提高、對標靶癌症治療的傾向不斷增加以及對個人化醫療的日益關注是推動成長的關鍵要素。此外，遺傳疾病罹患率的增加、分子細胞遺傳學領域的技術進步以及研發活動的活性化預計將在預測期內推動市場擴張。

此外，透過整合高通量測序進行的細胞遺傳學分析也是預計在未來年度顯著促進成長的要素之一。許多科學家和研究人員已經整合了NGS和細胞遺傳學實驗室，它們相互相容。因此，由於序列價格大幅下降，預計市場將以相當大的速度成長。

COVID-19的爆發對分子細胞遺傳學市場產生了積極影響。由於檢測優先順序發生變化，分子細胞遺傳學實驗室已轉向執行 COVID-19 診斷檢測。此外，對公共衛生基因組學的日益關注凸顯了分子細胞遺傳學在基於人群的基因組監測和追蹤疾病傳播中的價值，有助於制定有效的公共衛生策略。因此，大流行期間診斷測試的高發生率正在推動分子細胞遺傳學市場的成長。

症候群、地中海貧血和囊性纖維化等遺傳性疾病發病率的增加預計將在預測期內推動該領域的成長。例如，世界衛生組織估計，每 1,000 人中約有 10 人罹患遺傳疾病，相當於全世界約 7,000 至 8,000 萬人。此外，營運商針對細胞遺傳學工具技術進步的策略性舉措不斷增加，預計將推動分子細胞遺傳學市場的發展。例如，2022 年 10 月，Genoox 與 Thermo Fisher Scientific 合作推出了 CytoScan 自動解釋和報告 (AIR) 解決方案。該工具有望促進細胞遺傳學研究資料分析。

分子細胞遺傳學市場報告亮點

  • 從用途來看，2022年腫瘤領域佔據市場主導地位，佔有率為39.70%。這是因為 CGH 技術可以對癌症發病機制進行詳細研究。
  • 從按產品來看，由於人們對遺傳疾病和個人化醫療的了解和認知不斷增強，2022年消耗品將佔39.51%的佔有率。
  • 從技術面來看，由於更好的染色體分析技術不斷進步，比較基因組雜交領域將在 2022 年主導分子細胞遺傳學市場。
  • 按最終用途，臨床和研究實驗室部門佔 2022 年收益佔有率的大部分。同時，製藥和生物公司領域預計在預測期內將呈現最快的年複合成長率。
  • 2022年，由於技術進步、醫療保健基礎設施改善、大型企業的存在以及該地區藥物臨床試驗及其核准數量的增加，北美在該行業中佔據主導地位。

目錄

第1章 分子細胞遺傳學市場：調查方法與範圍

第2章 細胞遺傳學市場：執行摘要

  • 市場預測
  • 應用和技術簡介
  • 產品和最終用途簡介
  • 競爭形勢概覽

第3章 分子細胞遺傳學市場：市場變數、趨勢與範圍

  • 市場體系預測
  • 市場動態
  • 產業分析工具

第4章 分子細胞遺傳學市場：用途的商業分析

  • 分子細胞遺傳學市場：用途變異分析
  • 遺傳疾病
  • 腫瘤學
  • 個人化醫療
  • 其他用途

第5章 分子細胞遺傳學市場：技術的商業分析

  • 分子細胞遺傳學市場：技術變異分析
  • 比較基因組雜交
  • FISH
  • 免疫組織化學
  • 核型分析
  • 其他

第6章 分子細胞遺傳學市場：產品業務分析

  • 分子細胞遺傳學市場：產品變異分析
  • 裝置
  • 消耗品
  • 軟體和服務

第7章 分子細胞遺傳學市場：最終用途業務分析

  • 分子細胞遺傳學市場：最終用途變異分析
  • 臨床及研究機構
  • 醫院和路徑實驗室
  • 學術研究所
  • 製藥和生物技術公司
  • 其他

第8章 細胞遺傳學市場：區域業務分析

  • 區域市場簡介
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 分子細胞遺傳學市場：競爭形勢

  • 公司分類
  • 策略規劃
  • 2022 年公司市場佔有率分析
  • 公司簡介

第10章 KOL推薦/分析師觀點

Product Code: GVR-1-68038-023-1

Molecular Cytogenetics Market Growth & Trends:

The global molecular cytogenetics market size is anticipated to reach USD 4.46 billion by 2030, according to a new report by Grand View Research, Inc.. The market is expected to expand at a CAGR of 10.6% from 2023 to 2030. Rising penetration of molecular cytogenetics in clinical pathological testing, growing inclination towards targeted cancer treatment, and increasing focus on personalized medicine are the key factors driving growth. In addition, the increasing incidence of genetic disorders, technological advancements in the field of molecular cytogenetics, and rising R&D activities are anticipated to drive market expansion over the forecast period.

Furthermore, the cytogenetic analysis carried out through the integration of high throughput sequencers is another factor that is expected to significantly boost growth in the coming years. A number of scientists and researchers integrate NGS with cytogenetics laboratories as they are compliant with one another. Thus, with a significant drop in sequencing prices, the market is estimated to grow at a substantial pace.

The COVID-19 pandemic has positively impacted the market for molecular cytogenetics. Due to the shift in testing priorities, molecular cytogenetics laboratories were being redirected to conduct COVID-19 diagnostic testing. Furthermore, the increased focus on public health genomics has highlighted the value of molecular cytogenetics in population-based genomic surveillance and tracking disease spread, contributing to the development of effective public health strategies. Thus, the high incidence of diagnostic testing during the pandemic has fueled the growth of the market for molecular cytogenetics.

Increasing incidences of genetic disorders such as Down syndrome, Thalassemia, and Cystic Fibrosis are anticipated to fuel segment growth during the projected timeframe. For instance, according to WHO estimates, about 10 out of every 1000 people are affected with genetic disorders, which is approximately 70-80 million people globally. Moreover, rising strategic initiatives by operating players for technological advancements in cytogenetic tools are projected to propel the market for molecular cytogenetics. For instance, in October 2022, Genoox partnered with Thermo Fisher Scientific to introduce the CytoScan Automated Interpretation and Reporting (AIR) solution. This tool is expected to ease cytogenetic research data analysis.

Molecular Cytogenetics Market Report Highlights:

  • Based on application, the oncology segment dominated the market with a share of 39.70% in 2022, due to the capability of the CGH technology to avail detailed studies for cancer etiology
  • Based on product, consumables dominated the segment with a share of 39.51% in 2022, owing to the increasing knowledge and awareness regarding genetic diseases and personalized medicines
  • Based on technology, the comparative genomic hybridization segment dominated the market for molecular cytogenetics in 2022 due to the rising technological advancements for better chromosomal analysis
  • Based on end-use, the clinical & research laboratories segment held a majority of the revenue share in 2022. On the other hand, the pharmaceutical & biotech companies segment is anticipated to witness the fastest CAGR over the forecast period
  • In 2022, North America dominated the industry owing to the rising technological advancements, improving healthcare infrastructure, the presence of major players, and the increasing number of drug trials and their approvals in the region

Table of Contents

Chapter 1 Molecular Cytogenetics Market: Research Methodology And Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment Definitions
      • 1.1.1.1 Application Segment
      • 1.1.1.2 Technology Segment
      • 1.1.1.3 Product Segment
      • 1.1.1.4 End Use Segment
  • 1.2 Regional Scope
  • 1.3 Estimates and Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Abbreviations

Chapter 2 Molecular Cytogenetics Market: Executive Summary

  • 2.1 Market Outlook
  • 2.2 Application And Technology Snapshot
  • 2.3 Product And End Use Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Related/Ancillary Market Outlook
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Rapid technological advancements
      • 3.2.1.2 Increasing prevalence of genetic disorders
      • 3.2.1.3 Growing application in oncology
      • 3.2.1.4 Increasing demand for personalized medicine
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High Costs Of Testing
      • 3.2.2.2 Lack Of Reimbursement Policies
  • 3.3 Industry Analysis Tools
    • 3.3.1 Porter's Five Forces Analysis
    • 3.3.2 Pestel Analysis

Chapter 4 Molecular Cytogenetics Market: Application Business Analysis

  • 4.1 Molecular Cytogenetics Market: Application Movement Analysis
  • 4.2 Genetic Disorders
    • 4.2.1 Genetic Disorders Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Oncology
    • 4.3.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Personalized Medicine
    • 4.4.1 Personalized Medicine Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.5 Other Application
    • 4.5.1 Other Application Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis

  • 5.1 Molecular Cytogenetics Market: Technology Movement Analysis
  • 5.2 Comparative Genomic Hybridisation
    • 5.2.1 Comparative Genomic Hybridisation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 ACGH
      • 5.2.2.1 ACGH Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 SCGH
      • 5.2.3.1 SCGH Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Fish
    • 5.3.1 Fish Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Immunohistochemistry
    • 5.4.1 Immunohistochemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Karyotyping
    • 5.5.1 Karyotyping Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Spectral
      • 5.5.2.1 Spectral Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Virtual
      • 5.5.3.1 Virtual Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Molecular Cytogenetics Market: Product Business Analysis

  • 6.1 Molecular Cytogenetics Market: Product Movement Analysis
  • 6.2 Instruments
    • 6.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Consumables
    • 6.3.1 Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Software & Services
    • 6.4.1 Software & Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis

  • 7.1 Molecular Cytogenetics Market: End Use Movement Analysis
  • 7.2 Clinical & Research Laboratories
    • 7.2.1 Clinical & Research Laboratories Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Hospitals & Path Labs
    • 7.3.1 Hospitals & Path Labs Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Academic Research Institutes
    • 7.4.1 Academic Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Pharmaceutical & Biotech Companies
    • 7.5.1 Pharmaceutical & Biotech Companies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Others
    • 7.6.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Molecular Cytogenetics Market: Regional Business Analysis

  • 8.1 Regional Market Snapshot
  • 8.2 North America
    • 8.2.1 North America Molecular Cytogenetics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.2.2.2 Key Country Dynamics
      • 8.2.2.3 Regulatory Framework
      • 8.2.2.4 Reimbursement Scenario
    • 8.2.3 Canada
      • 8.2.3.1 Canada Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.2.3.2 Key Country Dynamics
      • 8.2.3.3 Regulatory Framework
      • 8.2.3.4 Reimbursement Scenario
  • 8.3 Europe
    • 8.3.1 Europe Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 UK Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.2.2 Key Country Dynamics
      • 8.3.2.3 Regulatory Framework
      • 8.3.2.4 Reimbursement Scenario
    • 8.3.3 Germany
      • 8.3.3.1 Germany Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.3.2 Key Country Dynamics
      • 8.3.3.3 Regulatory Framework
      • 8.3.3.4 Reimbursement Scenario
    • 8.3.4 Spain
      • 8.3.4.1 Spain Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.4.2 Key Country Dynamics
      • 8.3.4.3 Regulatory Framework
      • 8.3.4.4 Reimbursement Scenario
    • 8.3.5 France
      • 8.3.5.1 France Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.5.2 Key Country Dynamics
      • 8.3.5.3 Regulatory Framework
      • 8.3.5.4 Reimbursement Scenario
    • 8.3.6 Italy
      • 8.3.6.1 Italy Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.6.2 Key Country Dynamics
      • 8.3.6.3 Regulatory Framework
      • 8.3.6.4 Reimbursement Scenario
    • 8.3.7 Denmark
      • 8.3.7.1 Denmark Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.7.2 Key Country Dynamics
      • 8.3.7.3 Regulatory Framework
      • 8.3.7.4 Reimbursement Scenario
    • 8.3.8 Sweden
      • 8.3.8.1 Sweden Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.8.2 Key Country Dynamics
      • 8.3.8.3 Regulatory Framework
      • 8.3.8.4 Reimbursement Scenario
    • 8.3.9 Norway
      • 8.3.9.1 Norway Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.3.9.2 Key Country Dynamics
      • 8.3.9.3 Regulatory Framework
      • 8.3.9.4 Reimbursement Scenario
  • 8.4 Asia Pacific
    • 8.4.1 Asia-Pacific Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.2.2 Key Country Dynamics
      • 8.4.2.3 Regulatory Framework
      • 8.4.2.4 Reimbursement Scenario
    • 8.4.3 China
      • 8.4.3.1 China Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.3.2 Key Country Dynamics
      • 8.4.3.3 Regulatory Framework
      • 8.4.3.4 Reimbursement Scenario
    • 8.4.4 India
      • 8.4.4.1 India Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.4.2 Key Country Dynamics
      • 8.4.4.3 Regulatory Framework
      • 8.4.4.4 Reimbursement Scenario
    • 8.4.5 South Korea
      • 8.4.5.1 South Korea Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.5.2 Key Country Dynamics
      • 8.4.5.3 Regulatory Framework
      • 8.4.5.4 Reimbursement Scenario
    • 8.4.6 Thailand
      • 8.4.6.1 Thailand Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.6.2 Key Country Dynamics
      • 8.4.6.3 Regulatory Framework
      • 8.4.6.4 Reimbursement Scenario
    • 8.4.7 Australia
      • 8.4.7.1 Australia Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.4.7.2 Key Country Dynamics
      • 8.4.7.3 Regulatory Framework
      • 8.4.7.4 Reimbursement Scenario
  • 8.5 Latin America
    • 8.5.1 Latin America Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.5.2.2 Key Country Dynamics
      • 8.5.2.3 Regulatory Framework
      • 8.5.2.4 Reimbursement Scenario
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.5.3.2 Key Country Dynamics
      • 8.5.3.3 Regulatory Framework
      • 8.5.2.4 Reimbursement Scenario
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.5.4.2 Key Country Dynamics
      • 8.5.4.3 Regulatory Framework
      • 8.5.4.4 Reimbursement Scenario
  • 8.6 MEA
    • 8.6.1 MEA Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.2.2 Key Country Dynamics
      • 8.6.2.3 Regulatory Framework
      • 8.6.2.4 Reimbursement Scenario
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.3.2 Key Country Dynamics
      • 8.6.3.3 Regulatory Framework
      • 8.6.3.4 Reimbursement Scenario
    • 8.6.4 UAE
      • 8.6.4.1 UAE Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.4.2 Key Country Dynamics
      • 8.6.4.3 Regulatory Framework
      • 8.6.2.4 Reimbursement Scenario
    • 8.6.5 Kuwait
      • 8.6.5.1 Kuwait Molecular Cytogenetics Market, 2018 - 2030 (USD Million)
      • 8.6.5.2 Key Country Dynamics
      • 8.6.5.3 Regulatory Framework
      • 8.6.5.4 Reimbursement Scenario

Chapter 9 Molecular Cytogenetics Market: Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Strategy Mapping
    • 9.2.1 New product launch
    • 9.2.2 Partnerships
    • 9.2.3 Acquisition
    • 9.2.4 Collaboration
    • 9.2.5 Funding
  • 9.3 Company Market Share Analysis, 2022
  • 9.4 Company Profiles
    • 9.4.1 BIOVIEW
      • 9.4.1.1 Company overview
      • 9.4.1.2 Financial performance
      • 9.4.1.3 Product benchmarking
      • 9.4.1.4 Strategic initiatives
    • 9.4.2 DANAHER
      • 9.4.2.1 Company overview
      • 9.4.2.1.1 Leica Biosystems Nussloch GmbH
      • 9.4.2.2 Financial performance
      • 9.4.2.3 Product benchmarking
      • 9.4.2.4 Strategic initiatives
    • 9.4.3 METASYSTEMS
      • 9.4.3.1 Company overview
      • 9.4.3.2 Financial performance
      • 9.4.3.3 Product benchmarking
      • 9.4.3.4 Strategic initiatives
    • 9.4.4 AGILENT TECHNOLOGIES, INC.
      • 9.4.4.1 Company overview
      • 9.4.4.2 Financial performance
      • 9.4.4.3 Product benchmarking
      • 9.4.4.4 Strategic initiatives
    • 9.4.5 ABBOTT
      • 9.4.5.1 Company overview
      • 9.4.5.2 Financial performance
      • 9.4.5.3 Product benchmarking
      • 9.4.5.4 Strategic initiatives
    • 9.4.6 BIO-RAD LABORATORIES, INC.
      • 9.4.6.1 Company overview
      • 9.4.6.2 Financial performance
      • 9.4.6.3 Product benchmarking
      • 9.4.6.4 Strategic initiatives
    • 9.4.7 ILLUMINA, INC.
      • 9.4.7.1 Company overview
      • 9.4.7.2 Financial performance
      • 9.4.7.3 Product benchmarking
      • 9.4.7.4 Strategic initiatives
    • 9.4.8 OXFORD GENE TECHNOLOGY
      • 9.4.8.1 Company overview
      • 9.4.8.2 Financial performance
      • 9.4.8.3 Product benchmarking
      • 9.4.8.4 Strategic initiatives
    • 9.4.9 F. HOFFMANN-LA ROCHE LTD
      • 9.4.9.1 Company overview
      • 9.4.9.1.1 Genentech, Inc.
      • 9.4.9.2 Financial performance
      • 9.4.9.4 Product benchmarking
      • 9.4.9.5 Strategic initiatives
    • 9.4.10 PERKINELMER INC.
      • 9.4.10.1 Company overview
      • 9.4.10.2 Financial performance
      • 9.4.10.3 Product benchmarking
      • 9.4.10.4 Strategic initiatives
    • 9.4.11 QUEST DIAGNOSTICS INCORPORATED
      • 9.4.11.1 Company overview
      • 9.4.11.1.1 Sonora Quest Laboratories
      • 9.4.11.2 Financial performance
      • 9.4.11.3 Product benchmarking
      • 9.4.11.4 Product benchmarking
      • 9.4.11.5 Strategic initiatives
    • 9.4.12 APPLIED SPECTRAL IMAGING
      • 9.4.12.1 Company overview
      • 9.4.12.2 Financial performance
      • 9.4.12.3 Product benchmarking
      • 9.4.12.4 Strategic initiatives
    • 9.4.13 BIOLOGICAL INDUSTRIES USA, INC.
      • 9.4.13.1 Company overview
      • 9.4.13.2 Financial performance
      • 9.4.13.3 Product benchmarking
      • 9.4.13.4 Strategic initiatives
    • 9.4.14 CYTOTEST
      • 9.4.14.1 Company overview
      • 9.4.14.2 Financial performance
      • 9.4.14.3 Product benchmarking
      • 9.4.14.4 Strategic initiatives
    • 9.4.15 CYTOGNOMIX
      • 9.4.15.1 Company overview
      • 9.4.15.2 Financial performance
      • 9.4.15.3 Product benchmarking
    • 9.4.16 GENIAL GENETICS
      • 9.4.16.1 Company overview
      • 9.4.16.2 Financial performance
      • 9.4.16.3 Product benchmarking
      • 9.4.16.4 Strategic initiatives
    • 9.4.17 DIAGNOSTIC CYTOGENETICS, INC. (DCI)
      • 8.4.17.1 Company overview
      • 8.4.17.2 Financial performance
      • 8.4.17.3 Product benchmarking

Chapter 10 KOL Recommendations/Analyst Perspective

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 6. North America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 7. North America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 9. U.S. molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 10. U.S. molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 11. U.S. molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Canada molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 13. Canada molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 14. Canada molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 15. Canada molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 16. Europe molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 17. Europe molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 18. Europe molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 19. Europe molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 20. Europe molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 21. UK molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 22. UK molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 23. UK molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 24. UK molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Germany molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 26. Germany molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 27. Germany molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 28. Germany molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. France molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 30. France molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 31. France molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 32. France molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 33. Italy molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 34. Italy molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 35. Italy molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 36. Italy molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 37. Spain molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 38. Spain molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 39. Spain molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 40. Spain molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 41. Denmark molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 42. Denmark molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 43. Denmark molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 44. Denmark molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 45. Sweden molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 46. Sweden molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 47. Sweden molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 48. Sweden molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Norway molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 50. Norway molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 51. Norway molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 52. Norway molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Asia Pacific molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 54. Asia Pacific molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 55. Asia Pacific molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 56. Asia Pacific molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 57. Asia Pacific molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 58. China molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 59. China molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 60. China molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 61. China molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 62. Japan molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 63. Japan molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 64. Japan molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 65. Japan molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 66. South Korea molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 67. South Korea molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 68. South Korea molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 69. South Korea molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 70. Australia molecular cytogenetics market, by application 2018 - 2030 (USD Million)
  • Table 71. Australia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 72. Australia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 73. Australia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 74. Thailand molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 75. Thailand molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 76. Thailand molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 77. Thailand molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 78. India molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 79. India molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 80 India molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 81. India molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 82. Latin America molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 83. Latin America molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 84. Latin America molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 85. Latin America molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 86. Latin America molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 87. Brazil molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 88. Brazil molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 89. Brazil molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 90. Brazil molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 91. Mexico molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 92. Mexico molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 93. Mexico molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 94. Mexico molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 95. Argentina molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 96. Argentina molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 97. Argentina molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 98. Argentina molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 99. Middle East & Africa molecular cytogenetics market, by country, 2018 - 2030 (USD Million)
  • Table 100. Middle East & Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 101. Middle East & Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 102. Middle East & Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 103. Middle East & Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 104. South Africa molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 105. South Africa molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 106. South Africa molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 107. South Africa molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 108. Saudi Arabia molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 109. Saudi Arabia molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 110. Saudi Arabia molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 111. Saudi Arabia molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 112. UAE molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 113. UAE molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 114. UAE molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 115. UAE molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)
  • Table 116. Kuwait molecular cytogenetics market, by application, 2018 - 2030 (USD Million)
  • Table 117. Kuwait molecular cytogenetics market, by technology, 2018 - 2030 (USD Million)
  • Table 118. Kuwait molecular cytogenetics market, by product, 2018 - 2030 (USD Million)
  • Table 119. Kuwait molecular cytogenetics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Molecular cytogenetics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Segment snapshot
  • Fig. 12 Competitive landscape
  • Fig. 13 Molecular Cytogenetics Market Value, 2022 (USD Billion)
  • Fig. 14 Molecular Cytogenetics - Industry value chain analysis
  • Fig. 15 Molecular cytogenetics market dynamics
  • Fig. 16 Molecular cytogenetics market: PORTER's Five Forces analysis
  • Fig. 17 Molecular cytogenetics market: PESTEL analysis
  • Fig. 20 Molecular cytogenetics market: By application: Key takeaways
  • Fig. 21 Molecular cytogenetics market, by application: Market share, 2022 & 2030
  • Fig. 22 Genetic disorders market, 2018 - 2030 (USD Million)
  • Fig. 23 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 24 Personalized medicine market, 2018 - 2030 (USD Million)
  • Fig. 25 Other application market, 2018 - 2030 (USD Million)
  • Fig. 26 Molecular cytogenetics market: By technology: Key takeaways
  • Fig. 27 Molecular cytogenetics market, by technology: Market share, 2022 & 2030
  • Fig. 28 Comparative genomic hybridization market, 2018 - 2030 (USD Million)
  • Fig. 29 aCGH market, 2018 - 2030 (USD Million)
  • Fig. 30 sCGH market, 2018 - 2030 (USD Million)
  • Fig. 31 FISH market, 2018 - 2030 (USD Million)
  • Fig. 32 Immunohistochemistry market, 2018 - 2030 (USD Million)
  • Fig. 33 Karyotyping market, 2018 - 2030 (USD Million)
  • Fig. 34 Spectral market, 2018 - 2030 (USD Million)
  • Fig. 35 Virtual market, 2018 - 2030 (USD Million)
  • Fig. 36 Others market, 2018 - 2030 (USD Million)
  • Fig. 37 Molecular cytogenetics market: By product: Key takeaways
  • Fig. 38 Molecular cytogenetics market, by product: Market share, 2022 & 2030
  • Fig. 39 Instruments market, 2018 - 2030 (USD Million)
  • Fig. 40 Consumables market, 2018 - 2030 (USD Million)
  • Fig. 41 Software & services market, 2018 - 2030 (USD Million)
  • Fig. 42 Molecular cytogenetics market: By end use: Key takeaways
  • Fig. 43 Molecular cytogenetics market, by end use: Market share, 2022 & 2030
  • Fig. 44 Clinical & research laboratories market, 2018 - 2030 (USD Million)
  • Fig. 45 Hospitals & path labs market, 2018 - 2030 (USD Million)
  • Fig. 46 Academic research institutes market, 2018 - 2030 (USD Million)
  • Fig. 47 Pharmaceutical & biotech companies market, 2018 - 2030 (USD Million)
  • Fig. 48 Others market, 2018 - 2030 (USD Million)
  • Fig. 49 Molecular cytogenetics market revenue share, by region, 2022 & 2030 (USD Million)
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional marketplace: Key takeaways
  • Fig. 52 North America: SWOT analysis
  • Fig. 53 North America molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 Reimbursement procurement process
  • Fig. 56 U.S. molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Canada molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Europe: SWOT analysis
  • Fig. 60 Europe molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 UK molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 France molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Italy molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Spain molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Denmark molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Sweden molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Norway molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Asia Pacific: SWOT analysis
  • Fig. 78 Asia Pacific molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Reimbursement procurement process
  • Fig. 81 Japan molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 China molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 India molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 Australia molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Korea molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Thailand molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Latin America: SWOT analysis
  • Fig. 93 Latin America molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key country dynamics
  • Fig. 95 Brazil molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key country dynamics
  • Fig. 97 Mexico molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Argentina molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 MEA: SWOT analysis
  • Fig. 101 Middle East & Africa molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 South Africa molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 Key country dynamics
  • Fig. 105 Saudi Arabia molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 106 Key country dynamics
  • Fig. 107 UAE molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 108 Key country dynamics
  • Fig. 109 Kuwait molecular cytogenetics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 110 Key company categorization
  • Fig. 111 Company market position analysis
  • Fig. 112 Strategic framework